Archive
Vol. 24 No. 3 Sep.-Dec. 2007
Table of Contents
ORIGINAL ARTICLES
Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniaein Children at Queen Sirikit National Institute of Child Health
Napaporn Chaikittisuk M.Sc., Anurak Munsrichoom M.Sc.
Extended-spectrum β-lactamase (ESBL), producing Escherichia coli and Klebsiella pneumoniae, ESBLs, antibiotic susceptibility, prevalence
A Correlation between Phenotypes and Genotypes of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniaein a University Hospital, Thailand
Chanwit Tribuddharat M.D., Ph.D, Somporn Srifuengfung Ph.D, Wararat Chiangjong M.Sc.
Klebsiella pneumoniae, Extended-spectrum beta-lactamase (ESBL), phenotype, genotype
Further Observations on the Effects of Biocides (Antiseptics and Disinfectants) on the Endospores of Rhinosporidium seeberi, as Assayed by the MTTReduction Test
Navaratne Eriyagama , Sarath N. Arseculeratne MBBS, Dip.Bact., D.Phil.
Rhinosporidium seeberi, endospores, MTT-reduction test, biocide-sensitivity
Ocular Rhinosporidiosis with Staphyloma Formation: The First Report in Sri Lanka
Tissa Senaratne M.S., Saman Senanayake FRCS, Kapila Edussuriya DCEH, Padmini Wijenayake M.D., Sarath Arseculeratne D. Phil.
Ocular rhinosporidiosis, staphyloma formation, dapsone therapy
CASE REPORT
Tenosynovitis Caused by Mycobacterium kansasii: A Case Report and Literature Review
Thitirat Tangkosakul M.D., Poonpilas Hongmanee M.Sc., Pitak Santanirand Ph.D. , Somnuek Sungkanuparph M.D., Kornikar Wongnak B.Sc.
Mycobacterium kansasii, tenosynovitis, non-tuberculous mycobacteria
PHOTO QUIZ
REVIEW ARTICLE
Treatment of Clostridium difficile-Associated Diarrhea in the Era of Hypervirulence and Antibiotic Resistance
Anucha Apisarnthanarak M.D., Linda M. Mundy
Clostridium difficile, diarrhea, hypervirulence, emerging infectious diseases, treatment
INFECTIOUS DISEASE LITERATURE
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.
Somnuek Sungkanuparph M.D.